These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22629709)

  • 21. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic therapy for Barrett's esophagus and high grade dysplasia: results of a patient satisfaction survey.
    Hemminger LL; Wolfsen HC
    Gastroenterol Nurs; 2002; 25(4):139-41. PubMed ID: 12195146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
    Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M;
    Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.
    Gossner L; Stolte M; Sroka R; Rick K; May A; Hahn EG; Ell C
    Gastroenterology; 1998 Mar; 114(3):448-55. PubMed ID: 9496934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of photodynamic therapy in the esophagus.
    Gross SA; Wolfsen HC
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):35-53, vi. PubMed ID: 19951793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is symptom control the correct end point for proton pump inhibitor treatment in Barrett's oesophagus?
    Sarela AI; Verbeke CS; Pring C; Guillou PJ
    Gut; 2004 Sep; 53(9):1387-8. PubMed ID: 15306606
    [No Abstract]   [Full Text] [Related]  

  • 27. Barrett's esophagus.
    Falk GW
    Gastrointest Endosc Clin N Am; 1994 Oct; 4(4):773-89. PubMed ID: 7812646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia.
    Wolfsen HC
    Expert Rev Med Devices; 2005 Nov; 2(6):713-23. PubMed ID: 16293098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both?
    Sharma P; Wani S; Rastogi A
    Gastrointest Endosc; 2007 Sep; 66(3):469-74. PubMed ID: 17725936
    [No Abstract]   [Full Text] [Related]  

  • 30. Barrett's oesophagus: the new endoscopic modalities have a future.
    Deviere J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study].
    Zöpf T; Rosenbaum A; Apel D; Jakobs R; Arnold JC; Riemann JF
    Med Klin (Munich); 2001 Apr; 96(4):212-6. PubMed ID: 11370603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.
    Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY
    Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of Barrett's esophagus].
    Mabrut JY; Baulieux J
    J Chir (Paris); 1999 Dec; 136(6):301-8. PubMed ID: 10675819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophageal dysmotility in patients undergoing photodynamic therapy.
    Malhi-Chowla N; Wolfsen HC; DeVault KR
    Mayo Clin Proc; 2001 Oct; 76(10):987-9. PubMed ID: 11605700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New directions in endoscopic therapy of Barrett' s esophagus.
    Konda Vani JA; Chennat J; Waxman I
    Minerva Gastroenterol Dietol; 2010 Dec; 56(4):421-35. PubMed ID: 21139541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus.
    Behrens A; May A; Gossner L; Günter E; Pech O; Vieth M; Stolte M; Seitz G; Ell C
    Endoscopy; 2005 Oct; 37(10):999-1005. PubMed ID: 16189774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
    Hinnen P; de Rooij FW; van Velthuysen ML; Edixhoven A; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
    Br J Cancer; 1998 Sep; 78(5):679-82. PubMed ID: 9744510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus.
    Peters JH
    Gastrointest Endosc; 2010 Apr; 71(4):704-5. PubMed ID: 20363412
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical treatment of Barrett's esophagus: can it prevent cancer?
    Sampliner RE
    Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal endoluminal treatment of Barrett's esophagus: integrating novel strategies into clinical practice.
    Bisschops R
    Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):319-33. PubMed ID: 20528119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.